The new GOP spending bill proposal does not include sweeping changes to how pharmacy benefit managers (PBMs) operate, according to sources familiar with the matter. This decision comes as a surprise to many, as the initial bipartisan deal was expected to address the controversial practices of PBMs.
The bipartisan deal, which was part of the proposed legislation, aimed to introduce a series of reforms for PBMs. These middlemen, who stand between drug manufacturers and insurers, have faced criticism for their lack of transparency in pricing and rebate negotiations.
